Chemed Corp (NYSE:CHE)

CAPS Rating: 4 out of 5

The segment of the Company's business engages in a continuing program for the development and marketing of new services and products. It conducted its business operations in two segments: Vitas Group and Roto-Rooter Group.

Caps

How do you think CHE will perform against the market?

Add Stock to CAPS Watchlist

All Players

120 Outperform
20 Underperform
 

All-Star Players

34 Outperform
9 Underperform
 

Wall Street

5 Outperform
3 Underperform
 

Top CHE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

moonlightsail (21.37)
Submitted December 19, 2014

hospice care

DorMill (40.14)
Submitted July 01, 2008

Slow and steady wins the race. This stock creeps up bits at a time but you know, people still need their Roto Roter in good times and bad.

CHE VS S&P 500 (SPY)

Fools bullish on CHE are also bullish on:

Fools bearish on CHE are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CHE.

Recs

1
Member Avatar moonlightsail (21.37) Submitted: 12/19/2014 12:29:08 PM : Outperform Start Price: $104.32 CHE Score: +165.10

hospice care

Recs

0
Member Avatar turningpoint84 (53.59) Submitted: 9/3/2013 10:33:41 AM : Outperform Start Price: $67.13 CHE Score: +297.42

Everyone needs a plumber plus i see them expanding into other areas as others are trying to expand into theirs. I also for see Vitas growing better as they improve management, plus everybody dies.

Recs

0
Member Avatar paek813 (99.81) Submitted: 5/20/2013 12:38:22 PM : Outperform Start Price: $66.17 CHE Score: +306.09

S&P Fair Value Rank 5   

S&P Earnings & Dividend Rank A   

Relative Strength (RSI) 12   

ROE 20.6%

ROE 2Yrs. Ago 19.6%
______________________________________

- This company provides hospice services for patients with severe, life-limiting illnesses;

- and also provides plumbing and drain cleaning services.
______________________________________

May 3, 2013:

US Dept. of Justice says US has filed suit against CHE and various wholly owned hospice subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation, alleging false Medicare billings for hospice services.

April 19, 2013:

Chemed Corp. announced unaudited consolidated financial results for the first quarter ended March 31, 2013. For the quarter, the company reported service revenues and sales of $366.641 million against $352.943 million a year ago. Income from operations was $38.852 million against $34.977 million a year ago. Income before income taxes was $36.464 million against $33.455 million a year ago. Net income was $22.278 million or $1.17 per diluted share against $20.445 million or $1.06 per diluted share a year ago. Net cash provided by operating activities was $8.141 million against $10.381 million a year ago. Capital expenditures were $5.406 million against $12.018 million a year ago. Adjusted EBITDA was $51.296 million against $46.340 million a year ago. Adjusted net income was $26.140 million or $1.38 per diluted share against $23.340 million or $1.21 per diluted share a year ago. The management reaffirms previous guidance that full-year 2013 earnings per diluted share, excluding non-cash expense for stock options, the non-cash interest expense related to the accounting for convertible debt and other items not indicative of ongoing operations, will be in the range of $5.65 to $5.80. This compares to Chemed's 2012 reported adjusted earnings per diluted share of $5.29.

Leaderboard

Find the members with the highest scoring picks in CHE.

Score Leader

k650

k650 (72.30) Score: +901.20

The Score Leader is the player with the highest score across all their picks in CHE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
k650 72.30 10/2/2006 Outperform 5Y $27.78 +1,017.95% +116.75% +901.20 0 Comment
ABKBBB 41.67 4/25/2008 Outperform NS $29.52 +951.96% +104.18% +847.78 0 Comment
mmkerc 96.59 10/9/2006 Outperform 3Y $30.04 +933.76% +114.89% +818.87 0 Comment
C4M1 79.23 5/7/2008 Outperform 3M $31.19 +895.66% +99.44% +796.22 1 Comment
steelheadfishing 53.84 4/25/2008 Outperform NS $31.46 +887.24% +103.10% +784.14 0 Comment
Cheetohead 39.78 10/20/2006 Outperform 1Y $32.14 +866.26% +111.66% +754.60 0 Comment
z71chevydriver 29.86 6/9/2008 Outperform 1Y $32.59 +853.07% +106.58% +746.49 0 Comment
alwilder < 20 1/10/2007 Outperform 3W $32.67 +850.61% +106.15% +744.46 0 Comment
TLPrescott 89.35 5/22/2008 Outperform 1Y $32.84 +845.59% +103.18% +742.42 0 Comment
ugurmed < 20 6/2/2008 Outperform NS $33.11 +837.99% +102.48% +735.51 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJGreenblatt 58.79 8/16/2013 Outperform 1Y $70.70 +44.28% +19.40% +24.88 8/20/2014 @ $102.01 1 Comment
TrackUltraLong < 20 9/17/2012 Underperform NS $68.00 +356.74% +85.80% -270.93 1 Comment
TrackOppenheimer 59.56 2/17/2011 Outperform NS $60.27 +415.29% +104.57% +310.72 0 Comment
TrackBarclaysCap 88.71 10/27/2010 Underperform NS $55.84 +456.13% +131.35% -324.78 0 Comment
TrackJMP 83.11 7/31/2009 Outperform NS $44.03 +46.28% +29.12% +17.16 1/3/2011 @ $64.41 0 Comment
TrackArgus 89.47 6/18/2009 Underperform NS $36.04 +761.66% +200.86% -560.80 0 Comment
TrackRBCCapMkts 86.82 1/27/2009 Outperform NS $39.41 +27.42% +30.66% -3.24 2/17/2010 @ $50.21 0 Comment
TrackCLKing 71.76 7/28/2008 Underperform NS $38.11 -8.16% -23.23% -15.07 10/20/2008 @ $35.00 0 Comment
TrackEveillard 95.87 12/31/2007 Outperform NS $51.20 +506.56% +94.61% +411.95 1 Comment
TrackJohnKeeley < 20 12/31/2007 Outperform NS $55.72 -24.39% -10.19% -14.20 3/31/2008 @ $42.13 1 Comment
TrackRonBaron 81.70 9/30/2007 Outperform NS $56.89 +445.89% +87.48% +358.42 1 Comment
TrackJPMorgan 86.57 7/24/2007 Outperform NS $67.28 -52.13% -8.89% -43.23 4/28/2008 @ $32.21 0 Comment
TrackJefferies 80.38 6/14/2007 Outperform NS $60.82 +410.65% +89.82% +320.83 0 Comment
TrackDeutscheSec 86.00 5/7/2007 Outperform NS $61.31 +11.87% +2.52% +9.35 7/13/2007 @ $68.59 0 Comment
TrackJimCramer 85.25 3/8/2007 Outperform 3W $42.06 +638.31% +105.90% +532.41 0 Comment

Advertisement